Integra Lifesciences Holdings Corp

NASDAQ:IART   1:38:49 PM EDT
54.19
-0.38 (-0.70%)
Other Pre-Announcement

Integra Lifesciences Posts Q2 EPS Of $0.54

Published: 07/27/2022 10:58 GMT
Integra Lifesciences Holdings Corp (IART) - Integra Lifesciences Reports Second Quarter 2022 Financial Results.
Q2 Adjusted Earnings per Share $0.82.
Q2 GAAP Earnings per Share $0.54.
Q2 Revenue Rose 2 Percent to $398 Million.
Full Year 2022 Revenue Guidance Has Been Revised to a Range of $1,557 Million to $1,575 Million.
Tightening Previous Full-year 2022 Organic Growth Guidance of 3.8% to 5.2% to Updated Range of 4.0% to 5.2%.
Full Year 2022 Adjusted Earnings per Diluted Share Guidance is Updated to a Range of $3.21 to $3.29.
For Q3 2022, Company Expects Reported Revenues in Range of $383 Million to $391 Millio.
Integra Lifesciences Holdings- Qtrly Reported Revenues of $397.8 Million Increased 2.0% on a Reported Basis and 4.8% on an Organic Basis.
For Q3 2022, Co Expects Adjusted Earnings per Diluted Share is Expected to Be in a Range of $0.78 to $0.82.
Q2 Earnings per Share View $0.80, Revenue View $395.3 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $3.31, Revenue View $1.59 Billion -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share View $0.84, Revenue View $398.7 Million -- Refinitiv Ibes Data (analyst estimates).